Market Announcement 14 October 2026 14 October 2026 Market Announcement 1/1 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au Mayne Pharma Group Limited (ASX: MYX) – Trading Halt Trading in the securities of Mayne Pharma Group Limited (‘MYX’) will be halted at the request...
Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Mayne Pharma Group Limited has requested a trading halt for its securities pending an announcement related to a court decision. The halt will remain in effect until normal trading resumes or the announcement is released to the market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-1731
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings CallRelease
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Fulfilment of Imvexxy post-marketing study requirements
- Notification of cessation of securities - MYX
- MYX settles US patent litigation re Imvexxy with Sun Pharma
- Mayne Pharma announces legal settlement
- Date for Annual General Meeting
Later from Mayne Pharma
- Supreme Court Decision in Cosette Proceedings
- MYX settles US patent litigation re Imvexxy with Teva USA
- 2026 Notice of Annual General Meeting and shareholder pack
- Mayne Pharma reports unaudited Q1 FY27 results
- Investor presentation
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma